CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?

OBJECTIVE: To characterize biological and technical factors which influence cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarker levels, including the presence of apolipoprotein E (APOE) ε4 allele, AD diagnosis, Aβ-binding proteins, sample processing, and preanalytical handling. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: Hu, William T, Watts, Kelly D, Shaw, Leslie M, Howell, Jennifer C, Trojanowski, John Q, Basra, Sundeep, Glass, Jonathan D, Lah, James J, Levey, Allan I
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338954/
https://ncbi.nlm.nih.gov/pubmed/25750918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados